Resonance Health advises that it has appointed Mr. Mitchell Wells as a Non-Executive Director of the Company.
Mr. Wells replaces Dr. Jason Loveridge who resigned as a Non-Executive Director of the Company on 30 June 2017 to take up a senior position at a pharmaceutical company.
Mr. Wells is an experienced executive and a qualified lawyer with commercial and legal experience in Australia, the United States of America and the United Kingdom.
He has served as a director and worked as a senior executive of listed-public and private companies including ASX and Nasdaq listed companies. He currently serves as Chair of two not-for-profit organisations.
Since May 2017 Mr. Wells has provided corporate, legal and investor-relations consulting services to the Company and he will continue to consult to the Company for one or two days per week.
Dr. Martin Blake, Chairman of the Board, commented: “Mr. Wells is commercially focused and has played a key role in the corporate restructuring of the Company over the past 9 months and its re-energised focus on commercial outcomes. He has a strong governance background and has a thorough understanding of listed companies. The Board looks forward to continuing its work with him.”